4-Methylmorpholine → N-(2-aminophenyl)-5-(N-1,3-benzodioxol-5-ylglycyl)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamide

HRID 2093114Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2093114
[O:1]1[C:5]2[CH:6]=[CH:7][C:8]([NH:10][CH2:11][C:12]([OH:14])=O)=[CH:9][C:4]=2[O:3][CH2:2]1.ON1C2C=CC=CC=2N=N1.C(N=C=NCCCN(C)C)C.CN1CCOCC1.[NH2:43][C:44]1[CH:49]=[CH:48][CH:47]=[CH:46][C:45]=1[NH:50][C:51]([C:53]1[S:54][C:55]2[CH2:56][NH:57][CH2:58][CH2:59][C:60]=2[N:61]=1)=[O:52]>CN(C=O)C>[NH2:43][C:44]1[CH:49]=[CH:48][CH:47]=[CH:46][C:45]=1[NH:50][C:51]([C:53]1[S:54][C:55]2[CH2:56][N:57]([C:12](=[O:14])[CH2:11][NH:10][C:8]3[CH:7]=[CH:6][C:5]4[O:1][CH2:2][O:3][C:4]=4[CH:9]=3)[CH2:58][CH2:59][C:60]=2[N:61]=1)=[O:52]

Komponenten

7

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

To the solution of (Benzo[1,3]dioxol-5-ylamino)-acetic acid. (1.0 mmol) in dry DMF (10 mL), were added 1-hydroxybenzotriazole (1.2 mmol), 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide (2 mmol) and N-methylmorpholine (2.0 mmol). Solution was cooled to 0° C. N-(2-aminophenyl)-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamide. obtained in step VIII of Example 1 was then added and mixture was stirred at room temperature overnight. Reaction mixture was concentrated, diluted with water, extracted with dichloromethane, washed with brine solution, and dried over anhydrous Na2SO4. Concentrated and purified by column chromatograph to obtained the title compound.

Aufarbeitung

  1. customobtained in step VIII of Example 1
  2. additionwas then added
  3. customReaction mixture
  4. concentrationwas concentrated
  5. additiondiluted with water
  6. extractionextracted with dichloromethane
  7. washwashed with brine solution
  8. dry with materialdried over anhydrous Na2SO4
  9. concentrationConcentrated
  10. custompurified by column chromatograph

Quellen und Nachweise

ORD-Eintrag
ord-0df47081156449d4bddab5f547be9926
Quelldatensatz
uspto-grants-2013_05
Patentnummer
US08440830B2

Notizen zur Reaktion

Wird geladen…